Activist faces deportation
Trench played hand in death
City penalized $165K
More Carney endorsements
Boat capsized, sailor dead 
CN Rail strike notice
70 people killed in attack 
Rain on the way
Mass firing by Trump
Kia recalls 80,000 vehicles
Amazon stays course 
Markets shrug off tariff threat
Warriors streak ends at 4
Giants edge by Rockets
Blazers too much for P.G.
Tom Green finds peace
A$AP Rocky trial underway
No charges for Manson 
Photo: The Canadian Press
Bausch + Lomb Corp. logo is shown in a handout. The company says it's exploring several options including a potential sale of the company.
Bausch + Lomb Corp. says it's exploring several options including a potential sale of the company.
The company made the comment after a request by the Canadian Investment Regulatory Organization.
It says the company's board authorized management and its advisers to explore a potential sale, which is one of several options being examined to complete a full separation from Bausch Health Companies Inc.
It added that the process is ongoing and there is no assurance that it would result in a transaction.
Bausch + Lomb has a portfolio of about 400 products including contact lenses, lens care products, eye care products and other products.
The company was spun off from Bausch Health Companies, which continues to hold an 88 per cent stake.
